查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2044299

全球整體免疫代謝產品市場預測至2034年－按產品類型、成分類型、應用、通路、最終用戶和地區分類的分析

Holistic Immunometabolism Products Market Forecasts to 2034 - Global Analysis By Product Type, Ingredient Type, Application, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球整體免疫代謝產品市場規模將達到 57 億美元，並在預測期內以 13.2% 的複合年成長率成長，到 2034 年將達到 154 億美元。

整體免疫代謝產品是指產品類型，其重點在於免疫系統功能與代謝健康路徑之間的雙向關係。這類產品體認到，免疫細胞的活化狀態直接影響葡萄糖代謝、脂肪組織發炎和脂質代謝，而包括肥胖和胰島素抗性在內的代謝紊亂則會從根本上損害免疫功能。這些產品含有多種營養成分，能夠同時最佳化免疫通路並促進代謝健康，例如維生素D3、鋅、 Omega-3脂肪酸、槲皮素、小檜鹼、薑黃素、BETA-葡聚醣和特定的益生菌菌株。它們透過膳食補充劑、機能飲料、強化食品和醫用營養製劑等形式發揮作用，從而同時影響免疫和代謝兩方面。

疫情後人們對免疫和代謝健康的認知

新冠疫情的臨床證據表明，肥胖、第2型糖尿病和METABOLIC INC.症候群等代謝紊亂會顯著增加重症新冠的風險，並削弱疫苗的免疫反應，這提高了消費者對免疫和代謝健康之間聯繫的認知。在後疫情時代，人們正加大對預防性免疫和代謝健康干預措施的投入，以降低慢性疾病的風險。醫療專業人員進行的宣傳活動，將METABOLIC INC.的管理與最佳化免疫力聯繫起來，從而催生了對兼具免疫和代謝雙重功效的營養產品的臨床需求，這些產品能夠同時滿足這兩個健康需求。

對免疫和代謝健康的需求日益成長

消費者對免疫和代謝健康的需求日益成長，源於他們對免疫與代謝功能（例如能源平衡、發炎控制和腸道健康）之間聯繫的認知不斷提高。肥胖和糖尿病等文明病的激增，進一步推動了人們對預防性醫療保健解決方案的興趣。消費者正在積極尋求能夠同時增強免疫力和提高代謝效率的多功能產品。此外，營養科學的進步和個人化健康方法的出現，促進了產品的普及，而數位健康平台的擴展則提高了產品的可及性，並推動了市場的持續成長。

預防心臟和代謝疾病的營養方案

由醫生主導的、融合循證免疫代謝營養產品的心臟代謝疾病預防項目，為高階分銷管道提供了機會。基層醫療醫生和心臟代謝疾病專家在管理糖尿病前期、高血壓和超重患者群體時，越來越傾向於接受能夠同時改善代謝指標和最佳化免疫功能的臨床級營養干預措施。透過醫療專業人員推薦通路分銷醫學營養項目，可實現高價定價、長期病患留存，並產生驗證產品療效的臨床結果數據。

與製藥業在代謝健康管理領域的競爭

GLP-1受體促效劑在METABOLIC INC.症候群和肥胖症治療中的快速普及，對以消費者為導向的營養型免疫代謝健康產品構成了重大競爭威脅。隨著藥物體重管理和代謝最佳化療法在處方箋市場逐漸成為主流，消費者對營養代謝健康干預的投入可能會從主要的營養管理轉向補充劑的攝入，這需要重新評估產品定位策略。此外，推薦藥物代謝管理而非營養干預的臨床指引也可能帶來市場排斥的風險。

新冠疫情的感染疾病：

新冠疫情凸顯了代謝失控對免疫系統脆弱性的臨床影響，大大提高了人們對免疫代謝健康的認知。疫情期間，消費者對免疫代謝營養產品的投入激增，至今尚未恢復到疫情前的水平，而預防性營養產品購買量的結構性成長則維持了這一需求。疫情後，醫療系統將最佳化代謝健康作為應對疫情的韌性策略，這項措施持續推動醫療保健和消費者對綜合性免疫代謝營養產品的需求。

在預測期內，草藥製劑細分市場預計將佔據最大佔有率。

在預測期內，草藥製劑預計將佔據最大的市場佔有率。這主要歸功於全球主要市場消費者對傳統植物療法在免疫和代謝健康管理方面的強大信任。薑黃、生薑、睡茄、含小檜鹼的草藥以及紫錐紫錐花製劑，因其具有免疫和代謝雙重功效，正吸引著注重健康的消費者，他們尋求天然的代謝管理替代方案，而非藥物。此外，來自阿育吠陀和傳統中醫的權威機構支持，也為高階草藥免疫代謝製劑的市場定位提供了可靠的基礎。

預計在預測期內，維生素和礦物質細分市場將呈現最高的複合年成長率。

在預測期內，維生素和礦物質領域預計將呈現最高的成長率，這主要得益於疫情後大量臨床研究表明，某些微量營養素（例如維生素D、鋅、鎂和硒）缺乏是免疫功能障礙和METABOLIC INC.症候群的共同風險因素。消費者對這些雙重缺乏關聯的認知不斷提高，推動了對針對性微量營養素補充劑的投資。此外，醫療保健專業人員建議最佳化維生素D3和鋅的攝取量，以增強免疫力並改善胰島素敏感性，這催生了基於實證醫學的、近乎處方藥般的免疫代謝微量營養素製劑需求。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。這主要歸功於其全球領先的膳食補充劑消費支出、大規模的目標人口（由於代謝性疾病的高發，他們對免疫和代謝健康都有很高的需求）以及先進的機能性食品和膳食補充劑零售基礎設施。尤其值得一提的是，美國擁有根深蒂固的營養指導文化（從醫療保健專業人員到消費者），以及企業對員工代謝健康計畫的大量投資，這些都是其優勢所在。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。這主要歸因於多種因素：中國、印度和東南亞地區飲食結構的變化導致METABOLIC INC.症候群盛行率急劇上升；加上當地根深蒂固的傳統植物藥文化，消費者對植物來源免疫和代謝干預措施的認知度較高。此外，亞洲主要經濟體政府針對METABOLIC INC.症候群盛行率所進行的公共衛生項目，也催生了對實證免疫和代謝營養產品的機構需求。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 應客戶要求，我們提供主要國家的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章：執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球整體免疫代謝產品市場：依產品類型分類

  • 增強免疫力的補充劑
  • 新陳代謝、健康與營養
  • 機能飲料
  • 益生菌和益生元產品
  • 草藥製劑

第6章 全球整體免疫代謝產品市場：依成分類型分類

  • 維生素和礦物質
  • 植物萃取物
  • 益生菌
  • 蛋白質和胺基酸
  • 抗氧化劑

第7章 全球整體免疫代謝產品市場：依應用分類

  • 免疫支持
  • 代謝調控
  • 體重管理
  • 腸道健康
  • 預防慢性疾病

第8章 全球整體免疫代謝產品市場：依通路分類

  • 線上零售
  • 藥局
  • 超級市場和大賣場
  • 專賣店
  • 健康診所

第9章 全球整體免疫代謝產品市場：依最終用戶分類

  • 成人
  • 老年人
  • 健身愛好者
  • 慢性疾病患者
  • 孩子們

第10章：全球整體免疫代謝產品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Nestle SA
  • Abbott Laboratories
  • Danone SA
  • Herbalife Nutrition Ltd.
  • Amway Corporation
  • GSK plc
  • Bayer AG
  • Pfizer Inc.
  • DSM-Firmenich
  • BASF SE
  • Arla Foods
  • Fonterra Co-operative Group
  • GlaxoSmithKline Consumer Healthcare
  • Haleon plc
  • Nature's Bounty Co.
  • Blackmores Limited
  • Centrum（Pfizer）
Product Code: SMRC36088

According to Stratistics MRC, the Global Holistic Immunometabolism Products Market is accounted for $5.7 billion in 2026 and is expected to reach $15.4 billion by 2034 growing at a CAGR of 13.2% during the forecast period. Holistic immunometabolism products refer to a clinically-informed consumer nutrition category targeting the bidirectional relationship between immune system function and metabolic health pathways, recognizing that immune cell activation states directly influence glucose metabolism, adipose tissue inflammation, and lipid processing, while metabolic conditions, including obesity and insulin resistance, fundamentally impair immune competence. These products incorporate nutritional compounds that simultaneously address both immune pathway optimization and metabolic health including vitamin D3, zinc, omega-3 fatty acids, quercetin, berberine, curcumin, beta-glucans, and specialized probiotic strains, demonstrating dual immune-metabolic activity, delivered through supplements, functional beverages, fortified foods, and medical nutrition formulations.

Market Dynamics:

Driver:

Post-pandemic immune-metabolic health consciousness

COVID-19 pandemic clinical evidence demonstrating that metabolic conditions including obesity, type 2 diabetes, and metabolic syndrome, dramatically increased severe COVID-19 outcomes and impaired vaccine immune response, has created unprecedented consumer awareness of the immune-metabolic health connection. Post-pandemic populations globally are investing in preventive immunometabolic health interventions to reduce chronic disease vulnerability. Healthcare provider communication linking metabolic syndrome management with immune resilience optimization is creating clinical demand for dual-function immune-metabolic nutritional products that address both health priorities simultaneously.

Restraint:

Rising demand for immune-metabolic health

Rising demand for immune-metabolic health is driven by increasing consumer awareness of the link between immunity and metabolic functions such as energy balance, inflammation control, and gut health. The surge in lifestyle-related disorders, including obesity and diabetes, has intensified the focus on preventive healthcare solutions. Consumers are actively seeking multifunctional products that support both immune resilience and metabolic efficiency. Additionally, advancements in nutritional science and personalized health approaches are encouraging adoption, while expanding digital health platforms are improving accessibility and driving sustained market growth.

Opportunity:

Cardiometabolic disease prevention nutrition programs

Physician-guided cardiometabolic disease prevention programs incorporating evidence-based immunometabolic nutrition products represent a premium distribution channel opportunity. Primary care physicians and cardiometabolic specialist practitioners managing pre-diabetic, hypertensive, and overweight patient populations are increasingly receptive to clinical-grade supplemental nutrition interventions that support both metabolic parameter improvement and immune function optimization simultaneously. Medical nutrition program distribution through healthcare provider recommendation pathways enables premium pricing, long-term patient retention, and clinical outcome data generation that strengthens product claims.

Threat:

Pharmaceutical competition in metabolic health management

Rapidly expanding GLP-1 receptor agonist pharmaceutical adoption for metabolic syndrome and obesity management represents a significant competitive threat to consumer nutrition-based immunometabolic health products. As pharmaceutical weight management and metabolic optimization treatments achieve mainstream prescription penetration, consumer investment in nutritional metabolic health interventions may shift toward pharmaceutical-adjunct supplementation rather than primary nutritional management, requiring product repositioning strategy. Medical endorsement of pharmaceutical metabolic management over nutritional approaches in clinical guidelines creates potential market displacement risk.

Covid-19 Impact:

The pandemic dramatically elevated immunometabolic health awareness by demonstrating the clinical consequences of unmanaged metabolic conditions on immune system vulnerability. Consumer investment in immune-metabolic nutrition products surged during the pandemic and has not returned to pre-pandemic levels, with structural elevation in preventive nutrition purchasing sustaining demand. Post-pandemic, the healthcare system emphasis on metabolic health optimization as a pandemic resilience strategy continues driving institutional and consumer demand for holistic immunometabolism nutrition products.

The herbal formulations segment is expected to be the largest during the forecast period

The herbal formulations segment is expected to account for the largest market share during the forecast period, due to the deep consumer trust in traditional botanical medicine systems for immune and metabolic health management across major global markets. Turmeric, ginger, ashwagandha, berberine-containing herbs, and echinacea formulations with documented dual immune-metabolic activity command strong purchase intent among health-conscious consumers seeking natural alternatives to pharmaceutical metabolic management, with Ayurvedic and Traditional Chinese Medicine institutional backing providing credibility foundations for premium herbal immunometabolic formulation positioning.

The vitamins & minerals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the vitamins & minerals segment is predicted to witness the highest growth rate, driven by extensive post-pandemic clinical research documenting specific micronutrient deficiencies, including vitamin D, zinc, magnesium, and selenium as concurrent risk factors for both immune dysfunction and metabolic syndrome. Consumer awareness of these dual-deficiency connections is driving targeted micronutrient supplementation investment, and healthcare provider guidance linking vitamin D3 and zinc optimization to both immune resilience and insulin sensitivity improvement is creating evidence-based prescription-adjacent demand for immunometabolic micronutrient formulations.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to the highest global consumer supplement spending, high metabolic disease prevalence creating large addressable populations with combined immune-metabolic health needs, and advanced functional food and supplement retail infrastructure. The United States leads with strong healthcare provider-to-consumer nutrition guidance culture and substantial corporate investment in metabolic wellness employee health programs.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rapidly rising metabolic syndrome prevalence driven by dietary transition in China, India, and Southeast Asia, combined with established traditional botanical medicine cultures providing consumer familiarity with immunometabolic botanical interventions. Government population health programs addressing metabolic syndrome epidemics in major Asian economies are creating institutional demand for evidence-based immunometabolic nutrition products.

Key players in the market

Some of the key players in Holistic Immunometabolism Products Market include Nestle S.A., Abbott Laboratories, Danone S.A., Herbalife Nutrition Ltd., Amway Corporation, GSK plc, Bayer AG, Pfizer Inc., DSM-Firmenich, BASF SE, Arla Foods, Fonterra Co-operative Group, GlaxoSmithKline Consumer Healthcare, Haleon plc, Nature's Bounty Co., Blackmores Limited, and Centrum (Pfizer).

Key Developments:

In March 2026, Haleon plc launched a clinically formulated immunometabolic supplement combining vitamin D3, zinc, and berberine validated for simultaneous immune function and metabolic parameter optimization.

In March 2026, DSM-Firmenich introduced a precision immunometabolic ingredient blend for functional food and beverage fortification incorporating omega-3 concentrates and specialized probiotic cultures with dual immune-metabolic activity.

In February 2026, Abbott Laboratories released an immunometabolic medical nutrition product for metabolic syndrome patients incorporating targeted micronutrient complexes validated in randomized controlled clinical trials.

Product Types Covered:

  • Immunity Boosting Supplements
  • Metabolic Health Nutrition
  • Functional Beverages
  • Probiotic & Prebiotic Products
  • Herbal Formulations

Ingredient Types Covered:

  • Vitamins & Minerals
  • Botanical Extracts
  • Probiotics
  • Proteins & Amino Acids
  • Antioxidants

Applications Covered:

  • Immune Support
  • Metabolic Regulation
  • Weight Management
  • Gut Health
  • Chronic Disease Prevention

Distribution Channels Covered:

  • Online Retail
  • Pharmacies
  • Supermarkets/Hypermarkets
  • Specialty Stores
  • Health Clinics

End Users Covered:

  • Adults
  • Geriatric Population
  • Fitness Enthusiasts
  • Patients with Chronic Conditions
  • Children

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Holistic Immunometabolism Products Market, By Product Type

  • 5.1 Immunity Boosting Supplements
  • 5.2 Metabolic Health Nutrition
  • 5.3 Functional Beverages
  • 5.4 Probiotic & Prebiotic Products
  • 5.5 Herbal Formulations

6 Global Holistic Immunometabolism Products Market, By Ingredient Type

  • 6.1 Vitamins & Minerals
  • 6.2 Botanical Extracts
  • 6.3 Probiotics
  • 6.4 Proteins & Amino Acids
  • 6.5 Antioxidants

7 Global Holistic Immunometabolism Products Market, By Application

  • 7.1 Immune Support
  • 7.2 Metabolic Regulation
  • 7.3 Weight Management
  • 7.4 Gut Health
  • 7.5 Chronic Disease Prevention

8 Global Holistic Immunometabolism Products Market, By Distribution Channel

  • 8.1 Online Retail
  • 8.2 Pharmacies
  • 8.3 Supermarkets/Hypermarkets
  • 8.4 Specialty Stores
  • 8.5 Health Clinics

9 Global Holistic Immunometabolism Products Market, By End User

  • 9.1 Adults
  • 9.2 Geriatric Population
  • 9.3 Fitness Enthusiasts
  • 9.4 Patients with Chronic Conditions
  • 9.5 Children

10 Global Holistic Immunometabolism Products Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Nestle S.A.
  • 13.2 Abbott Laboratories
  • 13.3 Danone S.A.
  • 13.4 Herbalife Nutrition Ltd.
  • 13.5 Amway Corporation
  • 13.6 GSK plc
  • 13.7 Bayer AG
  • 13.8 Pfizer Inc.
  • 13.9 DSM-Firmenich
  • 13.10 BASF SE
  • 13.11 Arla Foods
  • 13.12 Fonterra Co-operative Group
  • 13.13 GlaxoSmithKline Consumer Healthcare
  • 13.14 Haleon plc
  • 13.15 Nature's Bounty Co.
  • 13.16 Blackmores Limited
  • 13.17 Centrum (Pfizer)

List of Tables

  • Table 1 Global Holistic Immunometabolism Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Holistic Immunometabolism Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Holistic Immunometabolism Products Market Outlook, By Immunity Boosting Supplements (2023-2034) ($MN)
  • Table 4 Global Holistic Immunometabolism Products Market Outlook, By Metabolic Health Nutrition (2023-2034) ($MN)
  • Table 5 Global Holistic Immunometabolism Products Market Outlook, By Functional Beverages (2023-2034) ($MN)
  • Table 6 Global Holistic Immunometabolism Products Market Outlook, By Probiotic & Prebiotic Products (2023-2034) ($MN)
  • Table 7 Global Holistic Immunometabolism Products Market Outlook, By Herbal Formulations (2023-2034) ($MN)
  • Table 8 Global Holistic Immunometabolism Products Market Outlook, By Ingredient Type (2023-2034) ($MN)
  • Table 9 Global Holistic Immunometabolism Products Market Outlook, By Vitamins & Minerals (2023-2034) ($MN)
  • Table 10 Global Holistic Immunometabolism Products Market Outlook, By Botanical Extracts (2023-2034) ($MN)
  • Table 11 Global Holistic Immunometabolism Products Market Outlook, By Probiotics (2023-2034) ($MN)
  • Table 12 Global Holistic Immunometabolism Products Market Outlook, By Proteins & Amino Acids (2023-2034) ($MN)
  • Table 13 Global Holistic Immunometabolism Products Market Outlook, By Antioxidants (2023-2034) ($MN)
  • Table 14 Global Holistic Immunometabolism Products Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Holistic Immunometabolism Products Market Outlook, By Immune Support (2023-2034) ($MN)
  • Table 16 Global Holistic Immunometabolism Products Market Outlook, By Metabolic Regulation (2023-2034) ($MN)
  • Table 17 Global Holistic Immunometabolism Products Market Outlook, By Weight Management (2023-2034) ($MN)
  • Table 18 Global Holistic Immunometabolism Products Market Outlook, By Gut Health (2023-2034) ($MN)
  • Table 19 Global Holistic Immunometabolism Products Market Outlook, By Chronic Disease Prevention (2023-2034) ($MN)
  • Table 20 Global Holistic Immunometabolism Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 21 Global Holistic Immunometabolism Products Market Outlook, By Online Retail (2023-2034) ($MN)
  • Table 22 Global Holistic Immunometabolism Products Market Outlook, By Pharmacies (2023-2034) ($MN)
  • Table 23 Global Holistic Immunometabolism Products Market Outlook, By Supermarkets/Hypermarkets (2023-2034) ($MN)
  • Table 24 Global Holistic Immunometabolism Products Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 25 Global Holistic Immunometabolism Products Market Outlook, By Health Clinics (2023-2034) ($MN)
  • Table 26 Global Holistic Immunometabolism Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 27 Global Holistic Immunometabolism Products Market Outlook, By Adults (2023-2034) ($MN)
  • Table 28 Global Holistic Immunometabolism Products Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 29 Global Holistic Immunometabolism Products Market Outlook, By Fitness Enthusiasts (2023-2034) ($MN)
  • Table 30 Global Holistic Immunometabolism Products Market Outlook, By Patients with Chronic Conditions (2023-2034) ($MN)
  • Table 31 Global Holistic Immunometabolism Products Market Outlook, By Children (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.